Why Physician-Supervised Weight Loss Beats DIY and Telehealth-Mill GLP-1
I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.
The internet has made GLP-1 medications easy to get. A few clicks, a checkbox form, and a vial shows up. But “easy to get” and “well managed” are not the same thing — and for a medication this powerful, the gap matters.
If you’re in Chattanooga, Signal Mountain, or anywhere in Tennessee weighing your options, here’s an honest comparison from Summit Metabolic Health, where Dr. Paul Miranda, MD, MBA — a board-certified physician, ER-trained — reviews every patient’s chart himself.
Most online GLP-1 services run on volume. A questionnaire gets processed by software (or skimmed by a nurse queue), a standard dose goes out, and you’re largely on your own from there. The DIY route — sourcing your own product and self-dosing — is riskier still.
Here’s why that’s a problem with these specific drugs:
These medications need a real screen first
GLP-1s carry a boxed warning for thyroid C-cell tumors and are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. A checkbox you click yourself is not the same as a physician reviewing your actual history. Getting this wrong isn’t a minor matter.
Side effects need active management
GI side effects — nausea, diarrhea, constipation, vomiting — are concentrated during the dose-escalation phase. With a fixed-dose, hands-off model, there’s no one to slow your titration when you’re struggling. The discontinuation rate for GI side effects was low in trials (about 4.5% in STEP 1, NEJM 2021), but that number reflects managed care, not a mailbox prescription — see how a physician-led program actually manages GLP-1 side effects for what that looks like week to week.
The exit strategy is where DIY fails worst
This is the big one. The trials are unambiguous: stopping the drug leads to substantial weight regain (STEP 4; SURMOUNT-4). And a lower maintenance dose holds your results far better than stopping cold (SURMOUNT-MAINTAIN, Lancet 2026). A telehealth mill has no incentive to plan your exit — your subscription is their revenue. DIY has no plan at all. We’ve written more on exactly how to come off a GLP-1 without regaining the weight, because a real exit plan is part of the medicine, not an afterthought.
A physician reads your chart — not a bot
At Summit, Dr. Miranda personally reviews your history, medications, and goals. Not a software questionnaire. Not a nurse queue. That’s the screen these drugs deserve.
Custom dosing, tuned to you
Summit uses custom-dosed compounded GLP-1 (semaglutide or tirzepatide), so the dose can be tailored to your tolerance and your progress — gentler when side effects flare, adjusted as you respond. Fixed-dose mills can’t do this. (If you’re wondering whether compounded semaglutide is safe in the first place, that’s a fair question worth answering directly.)
Results that justify the rigor
When these medications are used well, the data is strong (group averages from trials; individual results vary): semaglutide ~14.9% body-weight reduction at 68 weeks (STEP 1), and tirzepatide ~20.9% at 15 mg over 72 weeks (SURMOUNT-1). Used carelessly, you risk side effects, a missed contraindication, and regain.
A program that gets cheaper as you get healthier
Unlike a subscription mill, Summit’s program is designed with a descending price as you improve, plus a physician-directed maintenance and exit strategy. The goal is your long-term result — not your long-term billing.
Summit Metabolic Health serves patients across Tennessee, Florida, Washington, Ohio, and Georgia — in person in Chattanooga and by telehealth — so real physician supervision is within reach whether you’re on Signal Mountain or across the state.
Book a free 20-minute consultation and talk to a practice that treats GLP-1 weight loss like the medical care it is — or browse the Summit Metabolic Health blog for more on what real physician-led care looks like.
This article is for educational purposes only and is not medical advice. GLP-1 medications carry a boxed warning for thyroid C-cell tumors and require physician screening. Efficacy figures are group averages from clinical trials; individual results vary. Consult a qualified physician. Summit Metabolic Health · 200 W MLK Blvd Ste 1000, Chattanooga TN 37402 · (423) 407-7837 · info@summitmetabolic.health · summitmetabolichealth.com